120 related articles for article (PubMed ID: 38385211)
1. High-tissue FRMD6 expression predicts better outcomes among colorectal cancer patients.
von Koskull A; Hagström J; Haglund C; Kaprio T; Böckelman C
Biomarkers; 2024 May; 29(3):127-133. PubMed ID: 38385211
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemistry-Based Consensus Molecular Subtypes as a Prognostic and Predictive Biomarker for Adjuvant Chemotherapy in Patients with Stage II Colorectal Cancer.
Li Y; Yao Q; Zhang L; Mo S; Cai S; Huang D; Peng J
Oncologist; 2020 Dec; 25(12):e1968-e1979. PubMed ID: 32926498
[TBL] [Abstract][Full Text] [Related]
3. REG4 independently predicts better prognosis in non-mucinous colorectal cancer.
Kaprio T; Hagström J; Mustonen H; Koskensalo S; Andersson LC; Haglund C
PLoS One; 2014; 9(10):e109600. PubMed ID: 25295732
[TBL] [Abstract][Full Text] [Related]
4. High Tissue TLR5 Expression Predicts Better Outcomes in Colorectal Cancer Patients.
Beilmann-Lehtonen I; Hagström J; Mustonen H; Koskensalo S; Haglund C; Böckelman C
Oncology; 2021; 99(9):589-600. PubMed ID: 34139707
[TBL] [Abstract][Full Text] [Related]
5. Podocalyxin is a marker of poor prognosis in colorectal cancer.
Kaprio T; Fermér C; Hagström J; Mustonen H; Böckelman C; Nilsson O; Haglund C
BMC Cancer; 2014 Jul; 14():493. PubMed ID: 25004863
[TBL] [Abstract][Full Text] [Related]
6. FRMD6 has tumor suppressor functions in prostate cancer.
Haldrup J; Strand SH; Cieza-Borrella C; Jakobsson ME; Riedel M; Norgaard M; Hedensted S; Dagnaes-Hansen F; Ulhoi BP; Eeles R; Borre M; Olsen JV; Thomsen M; Kote-Jarai Z; Sorensen KD
Oncogene; 2021 Jan; 40(4):763-776. PubMed ID: 33249427
[TBL] [Abstract][Full Text] [Related]
7. Low expression of B-Cell-Associated protein 31 is associated with unfavorable prognosis in human colorectal cancer.
Ma C; Jin RM; Chen KJ; Hao T; Li BS; Zhao DH; Jiang H
Pathol Res Pract; 2018 May; 214(5):661-666. PubMed ID: 29653744
[TBL] [Abstract][Full Text] [Related]
8. Lysosomal acid phosphatase 2 is an unfavorable prognostic factor but is associated with better survival in stage II colorectal cancer patients receiving chemotherapy.
Lee YC; Su CY; Lin YF; Lin CM; Fang CY; Lin YK; Hsiao M; Chen CL
Oncotarget; 2017 Feb; 8(7):12120-12132. PubMed ID: 28076332
[TBL] [Abstract][Full Text] [Related]
9. FERM domain-containing protein 6 identifies a subpopulation of varicose nerve fibers in different vertebrate species.
Beck J; Kressel M
Cell Tissue Res; 2020 Jul; 381(1):13-24. PubMed ID: 32200438
[TBL] [Abstract][Full Text] [Related]
10. Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer.
Larsson A; Fridberg M; Gaber A; Nodin B; Levéen P; Jönsson G; Uhlén M; Birgisson H; Jirström K
BMC Cancer; 2012 Jul; 12():282. PubMed ID: 22769594
[TBL] [Abstract][Full Text] [Related]
11. Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by Immunohistochemistry.
Trinh A; Trumpi K; De Sousa E Melo F; Wang X; de Jong JH; Fessler E; Kuppen PJ; Reimers MS; Swets M; Koopman M; Nagtegaal ID; Jansen M; Hooijer GK; Offerhaus GJ; Kranenburg O; Punt CJ; Medema JP; Markowetz F; Vermeulen L
Clin Cancer Res; 2017 Jan; 23(2):387-398. PubMed ID: 27459899
[TBL] [Abstract][Full Text] [Related]
12. Plasma miR-122 and miR-200 family are prognostic markers in colorectal cancer.
Maierthaler M; Benner A; Hoffmeister M; Surowy H; Jansen L; Knebel P; Chang-Claude J; Brenner H; Burwinkel B
Int J Cancer; 2017 Jan; 140(1):176-187. PubMed ID: 27632639
[TBL] [Abstract][Full Text] [Related]
13. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
[TBL] [Abstract][Full Text] [Related]
14. The prognostic role of tissue TLR2 and TLR4 in colorectal cancer.
Beilmann-Lehtonen I; Böckelman C; Mustonen H; Koskensalo S; Hagström J; Haglund C
Virchows Arch; 2020 Nov; 477(5):705-715. PubMed ID: 32424768
[TBL] [Abstract][Full Text] [Related]
15. CA125: A superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242.
Björkman K; Mustonen H; Kaprio T; Kekki H; Pettersson K; Haglund C; Böckelman C
Tumour Biol; 2021; 43(1):57-70. PubMed ID: 33935125
[TBL] [Abstract][Full Text] [Related]
16. Relationship between LAPTM4B Gene Polymorphism and Prognosis of Patients following Tumor Resection for Colorectal and Esophageal Cancers.
Cheng X; Tian X; Wu X; Xing X; Du H; Zhou C; Zhang Q; Hao C; Wen X; Ji J
PLoS One; 2016; 11(7):e0158715. PubMed ID: 27391361
[TBL] [Abstract][Full Text] [Related]
17. DNA repair protein XPA is differentially expressed in colorectal cancer and predicts better prognosis.
Feng X; Liu J; Gong Y; Gou K; Yang H; Yuan Y; Xing C
Cancer Med; 2018 Jun; 7(6):2339-2349. PubMed ID: 29675892
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance and biological function of WD repeat domain 54 as an oncogene in colorectal cancer.
Yuan Y; Qi G; Shen H; Guo A; Cao F; Zhu Y; Xiao C; Chang W; Zheng S
Int J Cancer; 2019 Apr; 144(7):1584-1595. PubMed ID: 29987896
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of NETO2 expression correlates with tumor progression and poor prognosis in colorectal carcinoma.
Hu L; Chen HY; Cai J; Yang GZ; Feng D; Zhai YX; Gong H; Qi CY; Zhang Y; Fu H; Cai QP; Gao CF
BMC Cancer; 2015 Dec; 15():1006. PubMed ID: 26699544
[TBL] [Abstract][Full Text] [Related]
20. Low NLRP3 expression predicts a better prognosis of colorectal cancer.
Shi F; Wei B; Lan T; Xiao Y; Quan X; Chen J; Zhao C; Gao J
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33821998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
